GE HEALTHCARE TECHNOLOGY
GEHCNASDAQ🏆 #335 by market capUS Equity
$72.75▼ $0.20 (−0.27%)
Market closed · at close1h—
24h▼ 0.3%
7d—
14d—
30d—
1y—
🏦Market Cap
$32.86B
Mid Cap
📈Revenue Growth (YoY)
+6.5%
Slowing
📊Gross Margin
39.5%
Healthy
💵FCF Margin
7.4%
Moderate
⚖️P/S Ratio
1.5x
Cheap
Otter Score
44
Weak
No chart data available for GEHC.
Trading Snapshot
- Day Range
- $72.01 – $73.64
- 52-Week Range
- $58.75 – $89.77
- Volume
- $2.54B
- Avg Volume
- $3.35B
- Shares Outstanding
- 451.7M
- Next Earnings
- Sep 8, 2026
Fundamentals Snapshot
- Annual Revenue
- $21.21B
- Last Q Revenue
- $5.20B
- P/E Ratio
- 16.6
- P/S Ratio
- 1.5x
- EPS (TTM)
- $4.35
- Dividend Yield
- 0.19%
Why Investors Own GEHC
- ✓High-growth profile — revenue up -6.4% YoY with expanding US Equity exposure.
- ✓Healthy economics — 62% gross margin and 18% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$21.21B▼ −7.2% YoY
Gross Margin (TTM)
61.8%▲ +4.1% YoY
Operating Income (TTM)
$2.06B▼ −7.2% YoY
Free Cash Flow (TTM)
$3.84B▼ −7.2% YoY
About GE HEALTHCARE TECHNOLOGY
A company profile for GE HEALTHCARE TECHNOLOGY isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
44/100
Analyst Price Target
ⓘAverage Target
$82.14
▲ +12.9% Upside
High Target$102.08
Low Target$67.57
Based on 39 analysts
Latest News & Updates
🚀
Bloomberg·2h ago
GE HEALTHCARE TECHNOLOGY tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
CNBC·5h ago
Analysts lift GEHC price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Bloomberg·1d ago
GE HEALTHCARE TECHNOLOGY announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.